| Line Item | 2025-12-26 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $346.7M | — | -2.9% |
| Cost of Revenue | $43.2M | — | +6.0% |
| Gross Profit | $303.5M | — | -4.0% |
| R&D Expense | $69.1M | — | +3.7% |
| SG&A Expense | $70.2M | — | +0.2% |
| Operating Income | $62.2M | — | -22.2% |
| Pre-tax Income | $71.6M | — | -16.8% |
| Income Tax | $17.9M | — | -0.3% |
| Net Income | $53.3M | — | -21.4% |
| EPS (Basic) | $0.56 | — | -21.1% |
| EPS (Diluted) | $0.55 | — | -21.4% |
| Line Item | 2025-12-26 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $643.8M | -8.3% | +23.6% |
| Short-term Investments | $739K | +5.1% | — |
| Accounts Receivable | $373.1M | +12.7% | +10.0% |
| Inventory | $31.3M | +2.8% | -1.8% |
| Current Assets | $1.41B | +1.4% | +9.5% |
| Total Assets | $3.19B | -1.1% |
| Line Item | 2025-12-26 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $54.8M | — | -48.7% |
| Capital Expenditures | $4.6M | — | -31.7% |
| Investing Cash Flow | $1.2M | — | +115.3% |
| Financing Cash Flow | -$121.8M | — | -111.6% |
| Free Cash Flow | $50.2M | — | -49.8% |
| +1.1% |
| Current Liabilities | $443.5M | +1.3% | +0.4% |
| Total Liabilities | $589.3M | -1.1% | -8.2% |
| Stockholders' Equity | $2.59B | -1.1% | +3.4% |